<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02951494</url>
  </required_header>
  <id_info>
    <org_study_id>AlterG-Training-I Studie</org_study_id>
    <nct_id>NCT02951494</nct_id>
  </id_info>
  <brief_title>Impact of Lower Body Weight Support Treadmill on Cardiopulmonary Exercise Capacity and Trainability</brief_title>
  <official_title>Einfluss Der Körpergewichtsunterstützung Auf Einem AlterG®-Antigravitationslaufband Auf Die Kardiopulmonale Leistungsfähigkeit Und Trainierbarkeit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medicine Greifswald</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The AlterG®-anti-gravity treadmill provides lower body weight support which enables&#xD;
      individuals to exercise without feeling their full body weight. How this body weight support&#xD;
      influences cardiovascular, respiratory, vascular and metabolic parameters is currently&#xD;
      unclear. Further, whether body weight support influences the trainability in response to&#xD;
      moderate continuous exercise is unknown. This investigation has two main goals. First, we&#xD;
      explore the direct influence of lower body weight support on cardiometabolic parameters&#xD;
      during maximal exercise testing. Second, we aim to compare changes in cardiorespiratory&#xD;
      fitness in response to a structured exercise protocol using moderate intensity with and&#xD;
      without lower body weight support.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal oxygen consumption</measure>
    <time_frame>12 weeks</time_frame>
    <description>VO2peak [ml/min]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygen consumption at anaerobic threshold</measure>
    <time_frame>12 weeks</time_frame>
    <description>VO2@AT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse wave velocity</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>AlterG Anti-gravity treadmill</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>cont. aerobic exercise training with lower body weight support</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise without body weight support</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>cont. aerobic exercise training without lower body weight support</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>AlterG Anti-gravity treadmill</intervention_name>
    <description>Participants in this group will complete a 12 week aerobic exercise training protocol with 40% lower body weight support on an AlterG Anti-gravity treadmill</description>
    <arm_group_label>AlterG Anti-gravity treadmill</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  maximal oxygen consumption below age-sex specific standard&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  acute infection within the last four weeks&#xD;
&#xD;
          -  anemia (males: Hb &lt; 8.1 mmol/L; females Hb &lt; 7.4 mmol/L)&#xD;
&#xD;
          -  previous reports of myo-, endo, or pericarditis&#xD;
&#xD;
          -  previous stroke or acute myocardial infarction&#xD;
&#xD;
          -  heart failure (NYHA &gt; 1)&#xD;
&#xD;
          -  aortic valve stenosis&#xD;
&#xD;
          -  congenital heart disease&#xD;
&#xD;
          -  cardiomyopathy&#xD;
&#xD;
          -  severe left ventricular hypertrophy&#xD;
&#xD;
          -  cardiac arrythmias&#xD;
&#xD;
          -  hypertension&#xD;
&#xD;
          -  diabetes&#xD;
&#xD;
          -  BMI &gt; 35&#xD;
&#xD;
          -  cancer&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  aneurysm of aorta or cerebral arteries&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcus Dörr, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medicine Greifswald</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiovascular examination center of the University Medicine Greifswald</name>
      <address>
        <city>Greifswald</city>
        <zip>17489</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 12, 2016</study_first_submitted>
  <study_first_submitted_qc>October 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2016</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

